{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:52:51Z","timestamp":1761850371961,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmirs.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Imaging and Radiation Sciences"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jmir.2020.01.001","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T17:53:53Z","timestamp":1582739633000},"page":"264-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Value of PET-CT in Ovarian Epithelial Carcinoma: A Population-Based Study in British Columbia, Canada"],"prefix":"10.1016","volume":"51","author":[{"given":"Sarah Aurelia","family":"Cook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maral","family":"Pourghiasian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Violet","family":"Tinker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jmir.2020.01.001_bib1","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jmir.2020.01.001_bib2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.biopha.2018.01.094","article-title":"The promising PARP inhibitors in ovarian cancer therapy: From Olaparib to others","volume":"99","author":"Chen","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"9747","key":"10.1016\/j.jmir.2020.01.001_bib3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","article-title":"Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): a randomised trial","volume":"376","author":"Rustin","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jmir.2020.01.001_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ygyno.2007.07.082","article-title":"Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence","volume":"108","author":"Soussan","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.jmir.2020.01.001_bib5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3892\/ol.2012.1075","article-title":"Staging recurrent ovarian cancer with 18FDG PET\/CT","volume":"5","author":"Dragosavac","year":"2013","journal-title":"Oncol Lett"},{"issue":"10","key":"10.1016\/j.jmir.2020.01.001_bib6","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1007\/s00259-008-0890-2","article-title":"Diagnostic accuracy of integrated FDG-PET\/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT","volume":"35","author":"Kitajima","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.jmir.2020.01.001_bib7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MNM.0b013e3281afa256","article-title":"Diagnostic accuracy of 18F-FDG PET\/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology","volume":"28","author":"Castellucci","year":"2007","journal-title":"Nucl Med Commun"},{"issue":"3","key":"10.1016\/j.jmir.2020.01.001_bib8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ygyno.2013.08.020","article-title":"PET\/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer","volume":"131","author":"Dauwen","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.jmir.2020.01.001_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejrad.2008.02.019","article-title":"CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis","volume":"71","author":"Gu","year":"2009","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.jmir.2020.01.001_bib10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/IGC.0b013e31828a183c","article-title":"Accuracy of positron emission tomography\/computed tomography in the diagnosis and restaging for recurrent ovarian cancer: a meta-analysis","volume":"23","author":"Limei","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"Supplement 1","key":"10.1016\/j.jmir.2020.01.001_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ijgc-00009577-200602001-00016","article-title":"Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer","volume":"16","author":"Murakami","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.jmir.2020.01.001_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0090-8258(03)00336-6","article-title":"Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET\/CT","volume":"90","author":"Bristow","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.jmir.2020.01.001_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2006.03.004","article-title":"The impact of PET\/CT in the management of recurrent ovarian cancer","volume":"103","author":"Simcock","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.jmir.2020.01.001_bib14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00259-006-0306-0","article-title":"Integrated PET\/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer","volume":"34","author":"Mangili","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.jmir.2020.01.001_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.suronc.2017.07.004","article-title":"The role of F18-FDG PET\/CT in predicting secondary optimal de-bulking in patients with recurrent ovarian cancer","volume":"26","author":"Amit","year":"2017","journal-title":"Surg Oncol"},{"issue":"1","key":"10.1016\/j.jmir.2020.01.001_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2214\/ajr.182.1.1820227","article-title":"Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer","volume":"182","author":"Yoshida","year":"2004","journal-title":"AJR Am J Roentgenol"}],"container-title":["Journal of Medical Imaging and Radiation Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939865420300011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939865420300011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:47:51Z","timestamp":1761850071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939865420300011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1939865420300011"],"URL":"https:\/\/doi.org\/10.1016\/j.jmir.2020.01.001","relation":{},"ISSN":["1939-8654"],"issn-type":[{"type":"print","value":"1939-8654"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Value of PET-CT in Ovarian Epithelial Carcinoma: A Population-Based Study in British Columbia, Canada","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Imaging and Radiation Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmir.2020.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of Canadian Association of Medical Radiation Technologists.","name":"copyright","label":"Copyright"}]}}